Consistent, Standardized Frailty Assessments Could Improve Patient Outcomes
Researchers sought to identify frailty assessment tools and determine which are effective in patients undergoing hematopoietic stem cell transplantation.
Hematologic Cancers
Serious Long-Term Adverse Events Decreased in Pediatric Hodgkin Lymphoma
A deepened understanding of long-term effects can help clinicians to better determine upfront therapy and monitoring strategies for pediatric patients with Hodgkin lymphoma.
Extended Regimen With Carfilzomib, Lenalidomide, and Dexamethasone Is Effective in Newly Diagnosed Multiple Myeloma
An open-label, phase 2 trial was conducted at 10 centers in France and enrolled patients with sympotomatic, measurable newly diagnosed multiple myeloma.
Protocol for Nursing Care of Patients With Central Nervous System Lymphomas
This presentation discussed the key points of TEDDI-R protocol for managing the unique cluster of symptoms in patients with CNS lymphomas.
Prophylactic HD-MTX Does Not Improve CNS Relapse, Survival Outcomes in High-Risk DLBCL
A retrospective analysis was conducted to determine the safety and efficacy of high-dose methotrexate in patients with high-risk DLBCL.
Calorie Restriction May Increase Efficacy of Chemotherapy in Younger Patients With B-ALL
The IDEAL trial found that adolescents and young adults with B-cell acute lymphoblastic leukemia may benefit from restrictive diets and increased exercise.
Zynlonta Approved for Relapsed/Refractory Large B-Cell Lymphoma
Zynlonta (loncastuximab tesirine-lpyl) is a CD19-directed antibody and alkylating agent conjugate.
Whole-Genome Sequencing Shows Promise for Risk Stratification in AML, MDS
Researchers sought to determine whether whole-genome sequencing may be a better risk stratification tool compared with conventional cytogenetic analysis.
Engineered Cell Therapy AB-205 Shows Efficacy in Lymphoma With HDT-AHCT
Researchers sought to determine whether AB-205 would be a safe and effective therapy added to HDT-AHCT in adult patients with lymphoma.
Brentuximab Vedotin Shows Efficacy for Pediatric Patients With Classical Hodgkin Lymphoma
Researchers sought to determine the safety and efficacy of brentuximab vedotin in pediatric patients with classical Hodgkin lymphoma.
-
Loading...
-
Loading...
